Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. - Test2 - elhamkhani - TriplyDB

Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

http://www.wikidata.org/entity/Q29622903

about

Drug-eluting fibers for HIV-1 inhibition and contraception Reawakening retrocyclins: ancestral human defensins active against HIV-1 Asymmetric HIV-1 co-receptor use and replication in CD4(+) T lymphocytes HIV-1 induced bystander apoptosis HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans A lectin isolated from bananas is a potent inhibitor of HIV replication Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism Characterizing the anti-HIV activity of papuamide A Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1 Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity Pit2 assemblies at the cell surface are modulated by extracellular inorganic phosphate concentration Direct inactivation of human immunodeficiency virus type 1 by a novel small-molecule entry inhibitor, DCM205 An RNA targeted to the HIV-1 LTR promoter modulates indiscriminate off-target gene activation COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells Renal epithelial cells produce and spread HIV-1 via T-cell contact Real-time visualization of HIV-1 GAG trafficking in infected macrophages Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells Structural Insights into HIV-1 Vif-APOBEC3F Interaction The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans Diverse CD81 Proteins Support Hepatitis C Virus Infection Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies Allosteric Inhibition of Human Immunodeficiency Virus Integrase Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation High-affinity recognition of HIV-1 frameshift-stimulating RNA alters frameshifting in vitro and interferes with HIV-1 infectivity HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140 Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B Asymmetric deactivation of HIV-1 gp41 following fusion inhibitor binding The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex Fitness ranking of individual mutants drives patterns of epistatic interactions in HIV-1 Estimating the threshold surface density of Gp120-CCR5 complexes necessary for HIV-1 envelope-mediated cell-cell fusion Parental LTRs are important in a construct of a stable and efficient replication-competent infectious molecular clone of HIV-1 CRF08_BC Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7 Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis

P2860

Q21133885-904A1B5A-6BD9-41D5-B870-8A41953D4AEA Q21145822-2CCCC4E2-05BF-453E-A8A2-D3CC221DAE94 Q21245460-5583069D-E728-4485-936B-E289CBE25CB0 Q22241221-DAE2A929-2E5E-411B-9AC9-599E210EF495 Q24300016-2618E1A0-D95C-4960-B8C7-CCA2059B9C62 Q24524292-9E05CE2D-5EBE-422E-B7FE-F218DF6C9905 Q24530658-F7DFFC19-B414-47B7-9F7D-351B6CC9C851 Q24601035-C76B71BD-AF70-4B8C-9F8F-7C6D73C6144C Q24629155-4238128D-397C-4A8E-B5BB-C1B0A675CA7A Q24644811-F8DC5B83-EAE8-4F42-BAE0-E4D49CB887CB Q24645399-09EF1F8E-9259-4295-9CE3-548D0AFBFA38 Q24645530-A7AFE933-AC97-4972-967B-F4030C3CB950 Q24651042-8D327627-CBD8-4626-930F-43F4034E3A39 Q24672209-38B3B0C9-4739-497A-B65B-3F268B505FE2 Q24672232-4EB08984-D5FF-42D1-B27B-177940D32514 Q24673772-F5D0ED7E-79F4-4B3D-8D34-1B2B1A1D8633 Q24681004-9C0D37BB-153D-4F37-B1A1-88481881D67D Q24685792-A4AB3B96-6ED3-46F3-86EB-0E0C58081A20 Q24806175-B8819CAF-F4B4-4373-9797-C94BF17847E9 Q27313558-6EEB0C2A-AC5E-491E-80D9-950897A012AB Q27318996-3486AD7D-2B9D-4426-8097-77C82F6723C4 Q27320687-C52D64F3-642E-4DC2-A95B-3EDD0DADD97B Q27321018-F92E292C-C162-416E-BAE7-99DAD88B13D3 Q27472782-F223FB8D-9F56-4E46-AE68-DF4950FDE0DA Q27473420-CF565EBF-19B2-4886-9CDD-91241D6901BF Q27477625-A35AC046-B15B-48B2-928F-1EC7F4D8076D Q27487399-E051B88B-1EEC-4FD2-96D9-8C6BAB16ECF7 Q27644578-D7418592-371A-4534-B74A-64FC4850BA88 Q27670453-3E12F642-5E71-4393-AD75-9AF8DD3F4A0B Q28305122-2D4E4594-FE0D-4BCF-9FDE-D34B71F6CFAB Q28344746-7BA298CE-86C3-44AC-A973-AABBD7F111CF Q28345395-D10AB870-CB65-4AAF-9040-12BBB06A80BC Q28469023-25C99F9A-12EC-4C19-B813-E2843C9D9137 Q28471980-D847B8B6-BEFF-43EC-A4B4-CD3E34B5774B Q28474177-DE4FE15A-1B2C-4F6E-A0B0-90719AEA767A Q28477614-CF5B6DF6-7E90-4F1F-9C49-9EC0C9656853 Q28478341-2E693AB7-445F-445F-8286-8DCA30DB85DE Q28480941-45B7AF2A-F03B-4B24-B2BA-7646B73EC60C Q28482446-7CDA9DCE-E8BB-488F-8CBA-AB7F744BF79B Q28486428-69FBB94A-F12D-4E31-82E2-22F0231189DA

P2860

Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

http://www.wikidata.org/entity/Q29622903

description

1998 nî lūn-bûn

@nan

1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Effects of CCR5 and CD4 cell s ...... immunodeficiency virus type 1.

@ast

Effects of CCR5 and CD4 cell s ...... immunodeficiency virus type 1.

@en

type

label

Effects of CCR5 and CD4 cell s ...... immunodeficiency virus type 1.

@ast

Effects of CCR5 and CD4 cell s ...... immunodeficiency virus type 1.

@en

prefLabel

Effects of CCR5 and CD4 cell s ...... immunodeficiency virus type 1.

@ast

Effects of CCR5 and CD4 cell s ...... immunodeficiency virus type 1.

@en

P1433

Q29622903-06E288B3-D521-4F20-BD38-A7F147440716

P1476

Q29622903-F04D7916-C397-4861-992A-6F19FD898F95

P2093

Q29622903-06661D7C-1FFC-4BE2-86F7-5C4C6CCF64D0

Q29622903-1BC27991-B352-4224-8539-57D1EC27121E

Q29622903-20033015-953A-48A8-B943-39CB793BDF4A

Q29622903-756E646E-9E67-47C6-9520-FE7E68648CF9

Q29622903-8E3825A6-04AD-4DCF-85E3-37243AE4743E

P2860

Q29622903-03619E3D-F182-44E8-A8FD-6F7B8D50B062

Q29622903-04BEA1E7-7275-4F58-A9F0-BCC9F099F2FC

Q29622903-095AC001-A979-4747-BCE1-8710E01A9B0A

Q29622903-0B9ABC0A-9313-4B93-A849-6CC886FA2E9F

Q29622903-0F868C02-F119-496C-B907-28A0A0AD2F15

Q29622903-11AF133A-F2FE-4DA9-A637-373F8CF5BA98

Q29622903-1301FBB0-BA94-473D-9CBD-E6528CA6B88E

Q29622903-1501EB80-4D62-4ED5-9A05-892B7139C818

Q29622903-1664A9D1-CA50-4702-8C2C-9F6F3F563E42

Q29622903-20D9DF2A-2804-4893-8DD2-D96CE2C9F47E

P304

Q29622903-C191F9E2-8C29-4C80-96BD-9CA6C327B895

P31

Q29622903-B851AE84-9108-4896-84DE-9BD79891EC15

P3181

Q29622903-FD75D9E7-15B0-4275-B70C-09946DDF3FF8

P407

Q29622903-63D089D8-A5A4-42F2-8B29-0D40EE9DEC20

P433

Q29622903-DE1E1641-AEBD-4A97-95AC-23437EE563A1

P478

Q29622903-19E4130D-A76A-4351-AABC-E2E514D7D54D

P577

Q29622903-69296A5E-F2E9-49A3-954E-9357E704A4D2

P698

Q29622903-3B0883C5-258D-480D-BAEB-256DB64E46FD

P921

Q29622903-2AE63B72-E38D-47EC-9AFD-425CCB7F37B1

P932

Q29622903-F4E8E5FE-7090-4C3B-BE9C-DA4B23B3D564

P3181

P1433

Journal of Virology

P1476

Effects of CCR5 and CD4 cell s ...... immunodeficiency virus type 1.

@en

P2093

B Chesebro

http://www.w3.org/2001/XMLSchema#string

D Kabat

http://www.w3.org/2001/XMLSchema#string

E J Platt

http://www.w3.org/2001/XMLSchema#string

K Wehrly

http://www.w3.org/2001/XMLSchema#string

S E Kuhmann

http://www.w3.org/2001/XMLSchema#string

P2860

Coreceptors--Implications for HIV Pathogenesis and Therapy

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

Identification of a major co-receptor for primary isolates of HIV-1

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha

Physics of chemoreception

Multimeric CD4 binding exhibited by human and simian immunodeficiency virus envelope protein dimers

The envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

P304

2855-2864

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1005626

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

1998-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9525605

http://www.w3.org/2001/XMLSchema#string

P921

P932

109730

http://www.w3.org/2001/XMLSchema#string